Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Tong Shangguan

Safety of Nivolumab Plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer

Oncologist

English

Correction To: Developing Real-World Comparators for Clinical Trials in Chemotherapy-Refractory Patients With Gastric Cancer or Gastroesophageal Junction Cancer

English

Related publications

Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 Mg/Kg Plus Ipilimumab 3 Mg/Kg Expansion Cohort Results

Journal of Clinical Oncology

English

Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients

English

Prevalence and Characteristics of PIK3CA Mutation in Mismatch Repair-Deficient Colorectal Cancer

Journal of Cancer

Oncology

2020

English

Microsatellite Instability in the Mitochondrial DNA of Colorectal Carcinomas: Evidence for Mismatch Repair Systems in Mitochondrial Genome

English

Microsatellite Instability and Mutation of DNA Mismatch Repair Genes in Gliomas

American Journal of Pathology

Forensic Medicine

Pathology

1998

English

Pcn53 - Structured Literature Review of the Prevalence of Microsatellite Instability High (Msi-H) and Deficient Mismatch Repair (Dmmr) Among Solid Tumors

English

Estrogen Plus Progestin Use, Microsatellite Instability, and the Risk of Colorectal Cancer in Women

Cancer Research

Oncology

2007

English

Microsatellite Instability in Colorectal Cancer: Clinicopathological Significance

Polish Journal of Pathology

English

High Frequency of Microsatellite Instability in Sporadic Colorectal Cancer Patients in Iran

Genetics and Molecular Research

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Tong Shangguan

Safety of Nivolumab Plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer

Correction To: Developing Real-World Comparators for Clinical Trials in Chemotherapy-Refractory Patients With Gastric Cancer or Gastroesophageal Junction Cancer

Related publications

Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 Mg/Kg Plus Ipilimumab 3 Mg/Kg Expansion Cohort Results

Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients

Prevalence and Characteristics of PIK3CA Mutation in Mismatch Repair-Deficient Colorectal Cancer

Microsatellite Instability in the Mitochondrial DNA of Colorectal Carcinomas: Evidence for Mismatch Repair Systems in Mitochondrial Genome

Microsatellite Instability and Mutation of DNA Mismatch Repair Genes in Gliomas

Pcn53 - Structured Literature Review of the Prevalence of Microsatellite Instability High (Msi-H) and Deficient Mismatch Repair (Dmmr) Among Solid Tumors

Estrogen Plus Progestin Use, Microsatellite Instability, and the Risk of Colorectal Cancer in Women

Microsatellite Instability in Colorectal Cancer: Clinicopathological Significance

High Frequency of Microsatellite Instability in Sporadic Colorectal Cancer Patients in Iran